From July 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 42,941 shares, representing 0.29% for KRW 1,521.88 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,620 KRW | -0.06% |
|
+0.58% | -8.65% |
1st Jan change | Capi. | |
---|---|---|
-8.65% | 164M | |
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+26.13% | 16.51B | |
+21.19% | 14.6B | |
+71.91% | 14.27B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.